Objective To assess (1) the association between atrial cardiopathy (AC) and non-stenotic intracranial complicated atherosclerotic plaque (NICAP) in patients with embolic stroke of undetermined source ...

Read More on PubMed Atrial cardiopathy: a broadened concept of left atrial thromboembolism beyond atrial fibrillation. Kamel H. Hooman; Okin PM. Peter M; Longstreth WT. W T; Elkind MS. Mitchell S V; ...

Read More on PubMed Atrial cardiopathy: a broadened concept of left atrial thromboembolism beyond atrial fibrillation. Kamel H. Hooman; Okin PM. Peter M; Longstreth WT. W T; Elkind MS. Mitchell S V; ...

According to US secondary stroke prevention guidelines, patients with ESUS should not be treated with anticoagulants or ...

The council was birthed by the Traditional Medicine Practice Act, of 2000 (Act 575) to regulate the practice of traditional ...

Consequently, mitochondrial dysfunction, particularly in tissues with high energy demand, is central to the etiology of many complex pathologies including cancer, cardiopathy, neurodegeneration, aging ...

Atrial fibrillation is the most common cardiac complication of hyperthyroidism and occurs in 15% of patients with hyperthyroidism. It is associated with a higher risk of thromboembolism that often ...

Objective: Evaluate the effects of sodium-glucose cotransporter 2 inhibitor (SGLT2i) on cardiovascular and cerebrovascular diseases. Methods: Articles of SGLT2i on cardiovascular and cerebrovascular ...

Diabetes Mellitus/complications; Exercise/prevention & control; MicroRNAs; Heart Diseases; Angiogenesis Inducing Agents Considering this scenario, Mostafa et al. 7 7 Naderi R, Mohaddes G, Mohammadi M, ...

Dil Ki Bemari is a roman term that finds extensive usage in various sentences and different contexts. In English, the dil ki bemari is referred to as "Cardiopathy" and it is driven by the English ...

We are currently a StrokeNet site participant in the AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke (ARCADIA) trial. ARCADIA is a multicenter, biomarker-driven, ...